drugset / Trial / NCT00168298

A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion

NCT00168298 ↗

Phase 3 Completed 668 enrolled Allergan
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone for the treatment of macular edema associated with retinal vein occlusion.

Timeline

Start
2004-11-01
Primary completion
2008-03-01
Completion
2008-09-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 350 ug Intravitreal
Subject Dexamethasone Small molecule 700 ug Intravitreal